These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5899868)

  • 1. [Comparative pharmacological study of antitussive preparations derived from piperazine].
    Le Douarec JC; Régnier G; Canévari R
    Arzneimittelforschung; 1965 Nov; 15(11):1330-7. PubMed ID: 5899868
    [No Abstract]   [Full Text] [Related]  

  • 2. Some observations on the pharmacology of mitragynine.
    Macko E; Weisbach JA; Douglas B
    Arch Int Pharmacodyn Ther; 1972; 198(1):145-61. PubMed ID: 4626477
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent.
    Tersteege HM; Funcke AB; Louwerse WJ; Nauta WT
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):314-33. PubMed ID: 5926874
    [No Abstract]   [Full Text] [Related]  

  • 4. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol).
    Kobayashi S; Hasegawa K; Mori M; Takagi H
    Arzneimittelforschung; 1970 Jan; 20(1):43-6. PubMed ID: 5467447
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of ethyl dibunate, a new antitussive agent.
    Shemano I; Beiler JM; Hitchens JT
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):410-24. PubMed ID: 6031473
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitussive activity and other related pharmacological properties of 2-allyoxy-4-chloro-N-(2-diethylaminoethyl) benzamide.
    Kasé Y; Kawasaki A; Miyata T; Tsumagari T; Yuizono T
    Jpn J Pharmacol; 1966 Dec; 16(4):342-52. PubMed ID: 5298923
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological activities of a new antitussive agent: morphethylbutyne (2-phenoxy-isobutyric acid, 2-morpholine-ethyl ester).
    Marchetti E; Samueli F; Stucchi F
    Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):400-6. PubMed ID: 4242953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological properties of noscapine].
    Sukhinina GP
    Farmakol Toksikol; 1968; 31(6):702-5. PubMed ID: 4388890
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of antitussive effect of codeine by some 1-dimethoxyphenyl-3-alkylaminobutanols in guinea pigs.
    Kasuya Y; Watanabe M; Miyasaka K; Ishii Y
    Arzneimittelforschung; 1977 Jul; 27(7):1450-5. PubMed ID: 578470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
    Cosnier D; Hache J; Labrid C; Rispat G
    Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity.
    Rispat G; Burgi H; Cosnier D; Duchêne-Marullaz P; Streichenberger G
    Arzneimittelforschung; 1976 Apr; 26(4):523-30. PubMed ID: 8057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies of the pharmacological effects of the d- and l-isomers of codeine.
    Chau TT; Harris LS
    NIDA Res Monogr; 1981 Feb; 34():58-63. PubMed ID: 6783953
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of a new antitussive agent: meprotixol (N 7020).
    Hougs W; Nielsen IM; Norn S; Nymark M
    Acta Pharmacol Toxicol (Copenh); 1966; 24(1):3-23. PubMed ID: 6012748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)].
    Takagi H; Kobayashi S; Kumakura S; Mori M; Koike H
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):120-45. PubMed ID: 4390383
    [No Abstract]   [Full Text] [Related]  

  • 17. General pharmacology of the new antitussive levodropropizine.
    Melillo G; Malandrino S; Rossoni G; Caselli G; Bestetti A; Borsa M; Tonon GC; Berti F
    Arzneimittelforschung; 1988 Aug; 38(8):1144-50. PubMed ID: 3196408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on dl-glaucine phosphate as an antitussive.
    Kasé Y; Kawaguchi M; Takahama K; Miyata T; Hirotsu I; Hitoshi T; Okano Y
    Arzneimittelforschung; 1983; 33(7):936-46. PubMed ID: 6354197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gitan, 2-(beta-diethylaminoethyl)-3-phenylphthalimidine phosphate an antitussive agent.
    Hanna C
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):47-52. PubMed ID: 5470023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological studies on a substance with antitussive and respiration stimulating properties].
    Püschmann S; Engelhorn R
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:296-3. PubMed ID: 4145312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.